New Approaches in Cancer Drug Discovery
Author Information
Author(s): Sausville E A, Johnson J I
Primary Institution: Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute
Hypothesis
A new approach to cancer drug discovery targets molecules important in cancer pathogenesis.
Conclusion
The study suggests that a comprehensive understanding of cancer cell biology is essential for effective drug discovery.
Supporting Evidence
- A new approach to cancer drug discovery targets molecules important in cancer pathogenesis.
- The US National Cancer Institute maintains a cell-based drug discovery screen.
- The study emphasizes the importance of considering the cancer cell phenotype in drug development.
Takeaway
Scientists are trying to find better ways to create cancer medicines by looking at how cancer cells work as a whole, not just focusing on single parts.
Methodology
The study discusses a cell-based drug discovery screen that evaluates over 300 molecular targets in human tumor cell lines.
Limitations
The study acknowledges the complexity of cancer cell environments and the need for comprehensive drug action considerations.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website